Key result
Type 2 diabetes is linked to ~0.5 g/dL lower hemoglobin and obesity to higher platelets.
Why the study?
The increasing global prevalence of diabetes and obesity and their extensive complications make it important to clarify how glycemic control and obesity relate to hematological parameters.
Are type 2 diabetes and obesity associated with alterations in hematological parameters compared to healthy controls?
Cross-Sectional (n=1,037)
Are type 2 diabetes and obesity associated with alterations in hematological parameters compared to healthy controls?
Answers are grounded in this paper and cite their sources.
Type 2 diabetes is associated with reduced hemoglobin and hematocrit, whereas obesity is associated with elevated platelet count and RDW, potentially reflecting early metabolic/renal changes and chronic inflammation, respectively.
Background: Given the increasing global prevalence of diabetes and obesity and their extensive complications, understanding hematological alterations in these conditions is of particular importance. This study aimed to investigate the association between glycemic control and obesity with hematological parameters. Methods: This comparative cross-sectional study included 1037 individuals: 100 patients with type 2 diabetes, 217 obese individuals (BMI ≥ 30 kg/m²), and 720 healthy individuals (BMI < 25 kg/m²), selected in Kerman, Iran, during 2019–2020. Fasting blood samples (12–14 hours) were obtained to measure laboratory parameters including fasting blood glucose, hemoglobin A1C, complete lipid profile, and hematological indices (complete blood count). Results: Hemoglobin and hematocrit levels were significantly lower in the diabetic group than in controls (13.27 ± 0.14 vs. 13.73 ± 0.05 g/dL, p= 0.004; and 40.69 ± 0.42% vs. 42.19 ± 0.15%, p< 0.001, respectively; mean ± SEM). Platelet count was significantly higher in the obese group than in controls (250.63 ± 3.80 vs. 239.81 ± 2.24 × 10³/μL, p= 0.019). RDW was significantly higher in the obese group than in controls (14.29 ± 0.10% vs. 13.92 ± 0.04%, p< 0.001). Fasting blood glucose showed significant negative correlations with red blood cell count (r= −0.330), hemoglobin (r= −0.445), and hematocrit (r= −0.417) (all p< 0.001). Conclusion: Both diabetes and obesity are associated with significant alterations in hematological parameters. Reduced hemoglobin and hematocrit in diabetes may reflect early metabolic or renal changes, whereas elevated platelet count and RDW in obesity may indicate a chronic inflammatory state.
No takes yet. Share an insight, caveat, or question.
Afshar et al. (2026) conducted a cross-sectional in Type 2 diabetes and obesity (n=1,037). Type 2 diabetes and obesity (BMI ≥ 30 kg/m²) vs. Healthy individuals (BMI < 25 kg/m²) was evaluated on Hematological parameters (hemoglobin, hematocrit, platelet count, RDW, and RBC count) (p=0.004). Type 2 diabetes was associated with lower hemoglobin and obesity with higher platelets vs controls.
Synapse has enriched 10 related papers. Consider them for comparative context: